Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 2, 2019
Reporting Period: Fiscal third quarter ended February 28, 2019
This filing serves as a Regulation FD disclosure to furnish presentation slides regarding the company's fiscal third quarter performance. The information contained in the attached slides is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached presentation slides (Exhibit 99.1) rather than the body of the 8-K report.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. It references the existence of presentation slides discussing the fiscal third quarter but does not summarize the specific variances or trends within the text of this report.
Guidance, Outlook, and Risks
Management Commentary: The company is furnishing presentation slides dated April 2, 2019, which discuss the fiscal third quarter results.
Legal Status of Information: The information in the presentation slides is not incorporated by reference into other filings under the Securities Act of 1933.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this 8-K filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Presentation dated April 2, 2019) for specific revenue, profit, and cash flow figures.
- Verify the specific content of the fiscal third quarter discussion as it is not summarized in the 8-K text.
- Note that the presentation slides are not legally "filed" and are not incorporated by reference into other SEC filings.